Kevin K. Buckbee, an officer at AbbVie Inc., is set to sell 5,145 shares of the company's common stock on 02/29/2024, with an aggregate market value of $908,705.02. The shares to be sold were acquired through a mix of performance shares and retail purchases. A total of 5,099 shares were obtained as performance shares on two separate occasions, one batch on 02/28/2023 and the other on 02/28/2024. The remaining 46 shares were purchased in retail transactions spanning from 05/16/2022 to 02/15/2024. The sales notice was filed on the same day as the planned sale.

Kevin K. Buckbee, an officer at AbbVie Inc., is set to sell 5,145 shares of the company's common stock on 02/29/2024, with an aggregate market value of $908,705.02. The shares to be sold were acquired through a mix of performance shares and retail purchases. A total of 5,099 shares were obtained as performance shares on two separate occasions, one batch on 02/28/2023 and the other on 02/28/2024. The remaining 46 shares were purchased in retail transactions spanning from 05/16/2022 to 02/15/2024. The sales notice was filed on the same day as the planned sale.